Navigation Links
Grant funds West Coast Metabolomics Center
Date:9/5/2012

With a $9.3 million startup grant from the National Institutes of Health, the University of California, Davis, has announced plans to open the West Coast Metabolomics Center, a high-tech consortium of research and service laboratories that will help scientists better understand and develop more effective treatments for complex diseases like diabetes, cancer and atherosclerosis.

The facility, which will be housed within the UC Davis Genome Center, will celebrate its grand opening Oct. 8 with a mini-symposium featuring UC Davis and regional scientists, and corporate supporters.

Metabolomics is a new field that looks at the biochemical changes taking place in living cells during metabolism. The West Coast Metabolomics Center at UC Davis will use more than 30 mass spectrometers instruments for analyzing chemical structures to target thousands of different molecules produced in cells, allowing researchers to look at changes taking place at specific times and under specific environmental conditions.

"The NIH recognizes metabolism as a very important part of human physiology and disease processes," said Oliver Fiehn, professor of molecular and cellular biology and director of the new center. "When you analyze metabolism, you can tell the state of the body at the onset and during the progression of diseases ranging from cardiovascular disease to cancer."

The new center brings together existing UC Davis service facilities in mass spectrometry, nuclear magnetic resonance and imaging, with research labs across the campus, Fiehn said.

It will help researchers throughout the western U.S. with small grants for annual pilot and feasibility studies, provide courses, statistics and bioinformatics services, and perform metabolomic analyses on a fee-for-service basis. The center is designed to be self-sustaining within five years.

One of researchers who plans to use the new center is UC Davis Professor Bruce German, who st
'/>"/>

Contact: Andy Fell
ahfell@ucdavis.edu
530-752-4533
University of California - Davis
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. CU study awarded grant from Moore Foundation
2. Johns Hopkins Armstrong Institute receives $8.9 million patient safety grant
3. American College of Physicians awarded 3-year federal grant to increase adult immunization rates
4. Researchers awarded National Cancer Institute grants aimed at answering provocative questions
5. University of Colorado Cancer Center earns major grant to develop new bladder cancer drugs
6. UC San Diego, Yale awarded collaborative NSF grant for Neuroscience Gateway
7. GW School of Nursing receives nearly $1 million grant to diversify nursing workforce
8. Green biased yellow fever swept through Irish Immigrants in 19th century US
9. UT Southwestern investigators awarded $48.2 million in latest round of CPRIT grants
10. SU2C, Dutch Cancer Society announce new International Translational Cancer Research Grant recipients
11. Mayo Clinic Health System receives grant to improve rural health care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... to treat severe chronic migraine headaches led to significant ... in patients treated at Massachusetts General Hospital (MGH). ... Surgery report that more than half of 35 patients ... had headaches associated with compression of craniofacial nerves ... team,s paper has received advance online publication in the ...
(Date:7/28/2014)... Glutamine is the most abundant single amino ... conditionally essential during times when the body undergoes large ... Immune System Support. , Having a heavy work out ... with additional glutamine may be advantageous. Glutamine supplementation may ... digestion and immune system function. Stress on the body ...
(Date:7/28/2014)... 2014 (HealthDay News) --,The more chronic medical conditions people ... may be, a new study claims. Since ... issues, scientists at Johns Hopkins Bloomberg School of Public ... why gains in life expectancy are slowing in the ... as diabetes, kidney disease and heart failure is now ...
(Date:7/28/2014)... divide unless there is enough oxygen present to support ... types circumvent this rule. Researchers at The Johns Hopkins ... cells, warning signals, enabling cancers to continue to divide ... the researchers found that lysosomes the cell,s protein ... also uncovered new evidence that certain drugs can halt ...
(Date:7/28/2014)... NY (PRWEB) July 28, 2014 The ... organization that has donated more than 200,000 books to ... 2001, announces the launch of Brooke’s Cooks, a new ... while encouraging healthy living among at-risk children and their ... will include a series of nutrition information workshops, cooking ...
Breaking Medicine News(10 mins):Health News:Non-endoscopic migraine surgery provides significant symptom relief 2Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 2Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 3Health News:Chronic Medical Conditions Can Shorten Seniors' Lives: Study 2Health News:Cell's recycling center implicated in division decisions 2Health News:Brooke Jackman Foundation Launches Brooke's Cooks, New Initiative to Promote Healthy Living Among At-Risk Youth and Their Families 2Health News:Brooke Jackman Foundation Launches Brooke's Cooks, New Initiative to Promote Healthy Living Among At-Risk Youth and Their Families 3Health News:Brooke Jackman Foundation Launches Brooke's Cooks, New Initiative to Promote Healthy Living Among At-Risk Youth and Their Families 4
... 3 Endologix, Inc. (Nasdaq: ELGX ), developer of minimally ... and Chief Executive Officer, is scheduled to present at three upcoming ... Adams 3rd Annual Cardiovascular Conference at the Nikko Hotel in San ... Event: Canaccord Adams 3rd Annual Cardiovascular Conference, ...
... after the attacks, study shows , TUESDAY, Nov. 3 (HealthDay ... asthma rates twice that of the general population, a new ... and volunteers who had spent time at Ground Zero reported ... about 4 percent of the general population. The rate of ...
... , TUESDAY, Nov. 3 (HealthDay News) -- Experts have ... healthier than regular cigarettes, and new research suggests they ... less likely to quit, even those who switch specifically ... "switching to [,light, cigarettes] for any reason ...
... NBTY, Inc. (NYSE: NTY ) ( www.NBTY.com ... announced it will web cast a conference call to review fiscal ... ), on Monday, November 9, 2009 at 4:30 PM (ET). ... results will be issued at 4:00 PM (ET) that day. , ...
... COLUMBUS, Ohio, Nov. 3 National claims and risk management ... approach to claims management that ensures medical experts are involved ... company notes that the goal of the new service is ... the duration and overall cost of workers, comp claims. Avizent ...
... ... of the Health IT Standards Committee hearing held in Washington, D.C. last week, which was ... ... Orion Health Inc. endorses and commends the efforts of the Health IT Standards Committee ...
Cached Medicine News:Health News:Endologix to Present at Three Upcoming Conferences 2Health News:World Trade Center Workers Twice as Likely to Have Asthma 2Health News:World Trade Center Workers Twice as Likely to Have Asthma 3Health News:Switch to 'Light' Cigarettes Makes Quitting Tougher 2Health News:Switch to 'Light' Cigarettes Makes Quitting Tougher 3Health News:NBTY to Web Cast Fiscal Fourth Quarter Conference Call 2Health News:Avizent's New TeamCOMP Approach Helps Ensure Lower Workers' Comp Costs and Faster Claims Resolution 2Health News:Orion Health™ Participates in Health IT Standards Committee Hearing 2Health News:Orion Health™ Participates in Health IT Standards Committee Hearing 3Health News:Orion Health™ Participates in Health IT Standards Committee Hearing 4
(Date:7/28/2014)... 2014  Array BioPharma Inc. (Nasdaq:   ARRY) ... quarter and full year of fiscal 2014 ... those results on Tuesday, August 12, 2014.  ... Michael Carruthers , Chief Financial Officer will ... 2014Time:9:00 a.m. Eastern TimeToll-Free:(800) 708-4540Toll:(847) 619-6397Pass Code: ...
(Date:7/28/2014)... July 28, 2014  Syneron Medical Ltd. (NASDAQ: ... announced today that its new PicoWay® device has received ... and colors and pigmented lesions on any skin type. ... with 532nm and 1064nm wavelengths, which utilizes Syneron,s proprietary ... pulses which are trillionths of a second, known as ...
(Date:7/28/2014)... -- ResMed (NYSE: RMD ), an innovator and ... breathing and other chronic respiratory conditions, has won a ... Taiwanese medical device manufacturer APEX Medical Corp. (APEX), prohibiting ... and 220 masks.  The judgment was entered by the ... is appealable, and applies throughout Germany.  ...
Breaking Medicine Technology:Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 2Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 3Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 4ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe 2
... April 17, 2007,/PRNewswire-FirstCall/ -- Cell Genesys, Inc. ... conducted Phase 2 clinical trials,of GVAX immunotherapy ... patients with advanced prostate cancer from these,studies ... responses to a broad array of prostate ...
... A 9-month, randomized,double-blind, parallel-group Phase II study of ... given daily to the currently,approved COPAXONE(R) 20 mg ... disease activity as measured by magnetic,resonance images (MRI) ... mg experienced a reduced mean on-trial relapse rate,of ...
Cached Medicine Technology:Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces,a Broad, Patient-Specific Antibody Response 2Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces,a Broad, Patient-Specific Antibody Response 3Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces,a Broad, Patient-Specific Antibody Response 4Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 2Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 3Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 4Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 5
... The StatusFirst CHF test ... anti-NT-proBNP antibody/streptavidin solid-phase chromatographic ... a sample has been ... well, the StatusFirst CHF ...
... practices that need an ... Burdick Vision,Premier Holter System ... The Vision Premier system,adds ... a,more comprehensive list of ...
... EK-10 single-channel,electrocardiograph features a ... keypad. It provides the,necessary ... quick and,accurate diagnosis. The ... a built in handle ...
... contrast levels (high, 9.5 % and 6%) of ... is designed to detect very subtle changes in ... or due to refractive surgery. The upper two ... and acuity levels as the lower two rows; ...
Medicine Products: